EZbra™ Presented to the SESPRS 34th Annual 2018 Atlanta Breast Surgery Symposium

Tuesday, January 23, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

TEL AVIV, Israel, January 23, 2018 /PRNewswire/ --

EZbra, developer of a patented disposable post-surgical breast

dressing that provides tailor-made sterile, absorbent protection and compression, presented the benefits of EZbra™ at the SESPRS 34th Annual 2018 Atlanta Breast Surgery Symposium, January 19-21 at the Intercontinental Hotel
in Atlanta, GA. EZbra™ will be launched during 2018.

The EZbra™ breast dressing is an all-in-one medical device created to address the various needs and challenges that arise from all breast procedures: aesthetic, biopsy, lumpectomy, mastectomy, and reconstruction. EZbra's innovative design enhances the quality of care in accordance with surgeon post-op requirements, while allowing an independent patient dressing change and empowering patients to recover with dignity. EZbra™ allows the physician to adjust compression levels to any patient's specific breast shape and requirements, it can be adjusted for each breast side separately, providing a solution in cases of asymmetry, and can be used with implants as well as with DIEP flaps and autologous procedures. EZbra™ defines and fixates breast folds, stabilizes implants and holds drains, and can reduce OR and recovery room time, as well as recurring clinic visits.

EZbra is part of the emerging FemTech industry which focuses on women's healthcare and wellness. Company Founder and CEO Efrat Roman is a breast cancer survivor and she is also the founder of CureDiva.com, the 1st social commerce website for women dealing with breast cancer.

About EZbra™:

Ezbra aspires to create a uniformly accepted high-quality breast dressing for over 13 million women who undergo various types of breast procedures and surgeries annually. The company's flagship product, of the same, is an innovative and patented disposable post-surgical breast dressing that provides soft absorbent protection and compression. EZbra has commenced regulatory approval processes in North America. To date the company has raised $2.5 million and is headquartered in Tel Aviv, Israel.

Contact: Amalia Herszkowicz amalia@ezbra.net +972-502550555

SOURCE EZbra

Advertisement


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store